Mawer Investment Management Ltd. Charles River Laboratories International, Inc. Transaction History

Mawer Investment Management Ltd.

$21.3 Billion
Q4 2024

A detailed history of Mawer Investment Management Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mawer Investment Management Ltd. holds 46,629 shares of CRL stock, worth $7.25 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

46,629

Previous 40,860 14.12%

Holding current value

$7.25 Million

Previous $8.05 Million 6.93%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$178.58 - $220.69 $1.03 Million - $1.27 Million	5,769 Added 14.12%	46,629 $8.61 Million
Q3 2024 Nov 07, 2024	SELL	$187.96 - $245.29 $6.14 Million - $8.02 Million	-32,693 Reduced 44.45%	40,860 $8.05 Million
Q2 2024 Aug 07, 2024	BUY	$206.39 - $268.73 $5.77 Million - $7.51 Million	27,954 Added 61.3%	73,553 $15.2 Million
Q1 2024 May 06, 2024	BUY	$203.52 - $273.43 $3.98 Million - $5.35 Million	19,574 Added 75.21%	45,599 $12.4 Million
Q4 2023 Feb 07, 2024	BUY	$164.52 - $238.84 $1.15 Million - $1.68 Million	7,014 Added 36.89%	26,025 $6.15 Million
Q3 2023 Nov 06, 2023	BUY	$194.44 - $217.61 $339,103 - $379,511	1,744 Added 10.1%	19,011 $3.73 Million
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $263,440 - $301,498	1,434 Added 9.06%	17,267 $3.63 Million
Q1 2023 May 05, 2023	BUY	$191.89 - $259.92 $95,945 - $129,960	500 Added 3.26%	15,833 $3.2 Million
Q4 2022 Feb 07, 2023	BUY	$197.11 - $250.07 $545,206 - $691,693	2,766 Added 22.01%	15,333 $3.34 Million
Q3 2022 Nov 09, 2022	BUY	$182.44 - $250.54 $664,811 - $912,967	3,644 Added 40.84%	12,567 $2.47 Million
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $602,387 - $892,382	2,951 Added 49.41%	8,923 $1.91 Million
Q1 2022 May 06, 2022	BUY	$255.51 - $362.11 $776,750 - $1.1 Million	3,040 Added 103.68%	5,972 $1.7 Million
Q4 2021 Feb 09, 2022	BUY	$351.38 - $448.68 $674,298 - $861,016	1,919 Added 189.44%	2,932 $1.11 Million
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $377,484 - $464,257	1,013 New	1,013 $418,000

Others Institutions Holding CRL

# of Institutions

709

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.91B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mawer Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mawer Investment Management Ltd. with notifications on news.

Account

Mawer Investment Management Ltd. Charles River Laboratories International, Inc. Transaction History